Integrity Achievement Discipline Teamwork
WCCT's Management and Research Staff

  1. Kim, K., Apirion, D., and Ghora, B.: Small stable RNA of Newrospora crassa. Molecular and General Genetics 160:25-32, (1980).
  2. Patsch W., Kim, K., Wiest, W., and Schonfeld, G.: Effects of Sex Hormones on Rat Lipoproteins. Endocrinology 107 (4): 1085-94, (1980).
  3. Contributing author to the President's Commission for the Study of Ethical Problems in Medicine reports, "Splicing Life" (1982) and "Deciding to Forego Life-Sustaining Treatment" (1983).
  4. Black, K., Hawkin, R., Kim, K., Becker, D., Lerner, C., and Marciano, D. Use of Thallium-201 SPECT to Quantitative Malignancy Grade of Gliomas. Journal of Neurosurgery 71:342-46, (1989).
  5. Kim, K., Black, K., Marciano, D., Mazziota, J,, Guze, B., Grafton, S., Hawkings, R., Becker, D. Thallium-201 SPECT Imaging of Brain Tumors: Methods and Results. Journal of Nuclear Medicine, 31:965-969, (1990).
  6. Kim, K., Kwong, F., and Klaustermeyer, W. Use of OTC Afrin to Abort Anaphylaxis. Lancet, 341:439, 1993.
  7. Kim, K., Muhn, G., et Klaustermeyer, W. ChondroSARcoma presenting as asthma exacerbation Annals of Allergy, 72, 14-17, 1994.
  8. Kim, K. The Africanized Honey Bee: A Belated Arrival to California, New England Journal of Medicine, 331, 1776, 1994.
  9. Charous, B.L., Banov, C., Bardana, E., Blaiss, M., Hamilton, R, Kim, K., et. al.Latex allergy--an emerging healthcare problem. American College of Allergy, Asthma and Immunology position statement, Annals of Allergy, 75, 19-21, 1995.
  10. Kim, K. New Latex Allergy Policy Adopted, SCOPE, October 1995.
  11. Kim, K., Metcalfe, J., Sheikh, K., Miller, J., Edwards, R., Cown, S., Altadeff, G., Li, W. Recommendations for Hospital Risk Management of Latex Allergy, presented FLARE conference 10/12/96.
  12. Kim, K. "Latex Allergy" American Academy of Family Physicians Home study audiotape series, volume 214, March 1997.
  13. Kim, Kenneth T., "Latex Allergy-The Latest Insights", WJM, November 1997, Volume 167, No. 5.
  14. Kim, K., Safadi G., Sheikh, K. Diagnostic Evaluation of Type 1 Latex Allergy, Annals of Allergy, volume 80, January 1998, p 66.
  15. Kim, K., Graves, P., Safadi, G., Alhadeff, G., Metcaffe, J. Implementation Recommendations for Making Health Care Facilities Latex Safe, AORN Journal, 67, March 1998, pp. 615-632.
  16. Lee, M. Kim, K. Latex Allergy: A Relevant Issue in the General Pediatric Population, Journal of Pediatric Health Care, (1998), 12, 242-246.
  17. Hamilton, R., Adkinson, F., and the Multi-center Latex Skin Testing Study Task Force (Kenneth T. Kim, MD is part of the Multi-center Latex Skin Testing Study Task Force). Diagnosis of natural rubber latex allergy: Multi-center latex skin testing efficacy study, Journal of Allergy and Clinical Immunology, 102, 482-90, 1998.
  18. Hamilton, R., Adkinson, F., and the Multi-center Latex Skin Testing Study Task Force (Dr. Kenneth T. Kim, MD is part of the Multi-center Latex Skin Testing Study Task Force). Diagnostic Performance of FDA- Cleared Serological Assays for Natural Rubber Latex-Specific IgE Antibody, Journal of Allergy and Clinical Immunology, Vo1.80, No.1, 671-677,1999.
  19. Kim, K. and Hussain, H., Prevalence of Food Allergy in 137 Latex Allergic Patients, Allergy and Asthma Proceedings, Vo1.20, No.4, p.95-97, March-April 1999.
  20. Kim, K. and Safadi, G.S., Relation of latex-specific IgE titer and symptoms in patients allergic to latex, Journal of Allergy and Clinical Immunology, Vol. 103, No. 4, April 1999
  21. Kim, K, and Oguro, J., Update on the Status of Africanized Honey Bees in the Western States, Western Journal of Medicine, Vol. 170, No.4, April 1999
  22. Kim, K, Wellmeyer, E, and Miller, K., Minimum Prevalence of latex hypersensitivity in health care workers", Allergy and Asthma Proceedings, vo1.20, No.6, November-December 1999.
  23. Kim, K., Ginchansky, E., Friedman, B., Srebro, S., Pepsin, P., Edward, L., Standford, R. and Rickard, M., Fluticasone Propionate Versus Zafirlukast: Effect in Patients Previously Receiving Inhaled Corticosteriod Therapy, Annals of Allergy, Asthma, & Immunology, Vol. 85, No. 5, 398-406, November 2000.
  24. Milgrom H, Skoner DP, Bensch G, Kim KT, Claus R, Baumgartner RA, Low Dose Levalbuterol in Children with Asthma: Safety and Efficacy Compared With Placebo and Racemic Albuterol, Journal of Allergy and Immunology, Vol. 108, No. 6, 108:938-45, Dec. 2001.
  25. Skoner DP, Kim KT, Greos L, Levalbuterol in 2-5 Year Old Children with Asthma: Results of a Large Clinical Trial.
  26. Fluticasone Propionate Hydrofluoroalkane Inhalation Aerosol in Patients Receiving Inhaled Steroids Annals of Allergy, Asthma, and Immunology
  27. N.N.Kim, K.Y. Yoon, K.T. Kim, Sensitivity of Exhaled Nitrous Oxide In Detecting Airway Inflammation, Annals Of Allergy Asthma & Immunology, Jan 2005, 94{1)146:P87
  28. Kenneth T. Kim, MP, Edwark Kerwin, MD, Lawrence Landwehr, MD, Jonathan A. Bernstein, MD, Dawn Bruner, MD, Duane Harris, MD, Kristin Drda, PharmD, Jack Wanger, MS, and Chester C. Wood, MD Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies, Annals of Allergy Asthma & Immunology, Vol. 94, (1) January 2005
  29. Kim KT, Rabinovitch N, Uryniak T, Simpson B, O'Dowd L, Casty F, Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis, Annals of Allergy, Asthma & Immunology, 2004-Ju1;93(1):67-7
  30. Kenneth Kim, MD, Gordon Sussman, MD, Jacques Hebert, MD, William Lumry, MD, Barry Lutsky, PhD, Davis Gates, PhD Desloratadine therapy for symptoms associated with perennial allergic rhinitis, Annals of Allergy, Asthma & Immunology, March 2006; 96:460-465
  31. Richard L. Wasserman, MD, PhD, James W. Baker, MD, Kenneth T. Kim, MD, Kathryn V. Blake, PharmD, Catherine A. Scott, BA; Wei Wu, PhD; Melissa A. Faris, PharmD; Courtney Crim, MD, Efficacy and Safety of Inhaled Fluticasone Propionate CFC En 2-4 Year Old Patients with Asthma: Results of a Double-Blind, Placebo-Controlled Study; Annals of Allergy, Asthma and Immunology (IN PRESS)

  1. Kim, K., Dalton, J., and Klaustermeyer, W. Hypersensitivity Pneumonitis to Feathers: A Case Report, Annals of Allergy 70: 90, 1993.
  2. Kim, K., Kuhn, G, and Klaustermeyer, W. ChondroSARcoma Presenting as Asthma Exacerbation, Annals of Allergy 71, 173, 1993.
  3. Kim, K., Li, Wei-guo. Prevalence of Latex Allergy in Health Care Workers. Long Beach Memorial research symposium, November 17, 1995.
  4. Kim, K. Latex Allergy in Health care workers. World Congress of Korean Physicians, December 1995 meeting.
  5. Lee K, Klaustermeyer W, Kim K. Disseminated Gonococcal Infection and Strongyloides stercolis infection associated with C5 deficiency, Annals of Allergy, presented at American College of Allergy 1996 meeting.
  6. Smith, C, Garcia M, Kim K. Latex Exposure Causing Ulcerative Dermatitis, Journal of Allergy and Clinical Immunology, 99, 1 (1997), #1405.
  7. Lee KG, Klaustermeyer WB, Kim KT. Latex Provocation Challenge and Latex Allergy, Journal of Allergy and Clinical Immunology 99,1, (1997), #648.
  8. Kim, K., Sheikh, K. Diagnostic Evaluation of Type I Latex Allergy, Journal of Allergy and Clinical Immunology, 99, 1, (1997), # 2005.
  9. Williams, PB, Ownby D, Kim KT, Magera B. Comparing Two Methods for Assessing Specific IgE to Latex, European Academy Allergology, and Clinical Immunology 1997 meeting abstract.
  10. Tsai, P.B., Oh, C.K., Robinson, L.D., and Kim, K.T., Latex Prick Testing with Glove versus Raw Latex Extract. Annals of Allergy, volume 80, January 1998, p 93,57
  11. Miller KV, Altadeff G, Sheikh K, Kim KT. Prevalence of latex hypersensitivity in health care workers, Annals of Allergy, volume 80, January 1998,p101, P6.
  12. Miller, K., Kim, K.T., Minimum Prevalence of Latex Allergy In Health Care Workers, Annals of Allergy, volume 80, January 1998, p101, P6.
  13. Oda, K.K., Tsai, P.B., and Kim, K.T., Latex-induced Anaphylaxis Precipitated by Indirect Contact, Annals of Allergy, volume 80, January 1998, p 101, P7.
  14. Naran, N., and Kim, K.T., Long Standing Food Allergies Preceding Clinically Apparent Latex Allergy, Annals of Allergy, volume 80, January 1998, p 95, 67
  15. Tsai, P., Oh, C., Robinson, L., Kim, K., AlaSTAT vs. CAP Class for Predicting Latex-Related Symptoms in Patients Who Are RAST or Prick Positive to Latex, Journal of Allergy and Clinical Immunology, 101,1, (1998), #848.
  16. Hussain, H., Beall, G ., Kim, M., Prevalence of Food Allergy In Patients With Latex Allergy, Journal of Allergy and Clinical Immunology, 101, 1, (1998), #860.
  17. Kim, K., Hussain, H., Beall, G., Latex Allergy And IgE Antibodies To Foods, Journal of Allergy and Clinical Immunology, 101,1, (1998), #859.
  18. Hamilton, RG, Adkinson, NF, Bdak, ME, Golden, DBK, Stadtmauer, GJ, Graft, DF, Kim, KT, Slater JE, MacLean, JA, Husman, DW. Multicenter Latex Skin Testing Study, Journal of Allergy and Clinical Immunology, 101,1,(1998), #682.
  19. Yu, F.C. and Kim, K.T., Case Report of a Latex Allergic Physician who Tolerated BiogelTM Gloves, Annals of Allergy, Asthma, & Immunology 84, No.1, January 2000.
  20. Kim, J., Miller, S. and Kim, K., Occupational Management of the Type I Latex Allergic Patient, The Journal of Allergy and Clinical Immunology, 105, No. 1, January 2000.
  21. Kim, K., Blatter, M., Hayden, FG. and Coats, T., Pleconaril Treatment for Viral Respiratory Illness in Adults, Annals of Allergy, Asthma and Immunology, 2001; 86:86.
  22. Porch-Curren, C. and Kim, K., Longitudinal follow up of Latex-Specific IgE titers in Health Care Workers, Journal of Allergy and Clinical Immunology 2001, 107, No. 1, S128.
  23. Hayden FG, Kim K, Hudson S. Pleconaril treatment reduces duration and severity of viral respiratory infection (common cold) due to picornaviruses. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. December 2001 (abstract H-659)
  24. Chiang, D., Kim K., Prevalence of Arabic and Karaya Gum Allergy in Latex-Allergic patients, Journal of Allergy and Clinical Immunology 2002,109. No 1, S333.
  25. Skoner DP, Kim KT, Greos L, Levalbuterol in 2-5 Year Old Children with Asthma: Results of a Large Clinical Trial Annals of Allergy , Asthma, and Immunology 2003;90:127
  26. Chipps, B., Kim, K., Korenblat, P., Deniz, Y., Zheng, B., Carroll, A., Effect of Omalizumab on Health Care Utilization in Patients with Moderate to Moderate to Severe Allergic Asthma. Journal of Allergy & Clinical Immunology Feb 2003, 111, No 2, #301
  27. Hayden, F.G., Belshe, R., Delfin, E., Kim, K., Lanno, R., Hughes, C., Small, I., Dutkowski, R., Ward, P., Carr, J., Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without post-exposure prophylaxis
  28. Hayden, F.G., Kim, K., Hudson, S., Villano, S.A., & The Pleconaril Respiratory Infection Study Group, Pleconaril Treatment Provides Early Reduction of Symptoms Severity in Viral Respiratory Infection (VRI) Due to Picornaviruses. 39th Annual Meeting of the Infectious Diseases Society of America, San Francisco, CA. 2001; 414
  29. Hayden, F.G., Coats, T., Kim, K., Hassman, H.A., Blatter, M.M., Zhang, B., Liu, S., Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in Phase II clinical trials, Antiviral Therapy,; Vol. 7 No. 1, 53-65 March 2002
  30. Kim, K., Uryniak, T., Simpson, B., O'Dowd, L., Casty, F., Once-Daily Budesonide Aqueous Nasal Spray (BANS) Does Not Suppress Hypothalamic-Pituitary-Adrenal (HPA) Axis Function in Children 2 to 5 Years of Age With Allergic Rhinitis Journal of Allergy & Clinical Immunology Feb 2003, 111, No 2, #37
  31. Wasserman, RL, Kim, KT, Blake, KV, Herje, NG, Scott, CA, Wu, W, Crim, CC, Barnhart, FH, Reisner, CC, "Fluticasone Propionate is Safe in Treating Pre-School Age Children (24-47 Months) with Asthma, Journal of Allergy & Clinical Immunology, Feb 2003, 111, No 2 #601
  32. Kim, KT, Sussman, GL, Hebert, J, Lumry, WR, Lutsky, B, Gates, D, Effect of Once Daily Desloratadine in Patients with Perennial Allergic Rhinitis:, A Double Blind, Placebo Controlled Study. Journal of Allergy and Clinical Immunology Feb 2003, 111, No 2, #25
  33. Chipps, B., Kim, K., Korenblat, P., Deniz, Y., Carroll, A., Effect of Omalizumab on Healthcare Utilization in Patients with Moderate to Severe Allergic Asthma. Journal of Allergy & Clinical Immunology Feb 2003, 111, No 2, #301
  34. Yoon, K., Halsey, JF., Kim, KT., Antigenic Latex Protein From rubber bands. Journal of Allergy & Clinical Immunology, Feb 2004, 113, No 2, #208
  35. Busse, WW., Baker, JW., Chaurous, BL., Chervinsky, P., Kim, KT., Gross, GN., Korenblat, PE., Shames, RS., Preliminary Safety and Efficacy of Daclizumab in the Treatment of Patients With Moderate to Severe Chronic Persistent Asthma. Journal of Allergy & Clinical Immunology, Feb 2004, 113, No 2, #1043
  36. Kim, K., Uryniak, T., Simpson, B., O'Dowd, L., Casty, F., Once-Daily Budesonide Aqueous Nasal Spray (BANS) Does Note Suppress Hypothalmic-Pituitary-Adrenal (HPA) Axis Function in Children 2 to 5 Years of Age With Allergic Rhinitis. Annals of Allergy, Asthma & Clinical Immunology Jul 2004, 93(1):61-7
  37. Busse WW, Baker JW, Lisberg EE, Charous BL, Chervinsky P, Kim KT, Gross GN, Korenblat PE, Shames RS., Preliminary Safety And Efficacy Of Daclizumab In The Treatment Of Patients With Moderate To Severe Chronic Persistent Asthma. Journal of Allergy & Clinical Immunology (Submitted)
  38. Safety and Efficacy of Ipratropium Bromide Nasal Spray 0.06% in Children 2 to 5 Years of Age with Rhinorrhea Associated with a Common Cold or Allergy. Annals of Allergy, Asthma & Clinical Immunology Jan 2005, 94(1):73-79
  39. Nelson HS, Busse WW, Israel E, Baker JW, Charous BL, Kim KT, Gross GN, Corren J, Young D, Shames RS., Daclizumab Improves Asthma Control in Patients with Refractory Asthma. Journal of Allergy & Clinical Immunology, Feb 2005, 115(2), S302 #534
  40. H.P. Spyers-Duran, T. T. Kim, Psychogenic reaction to Xolair. Abstract Book ACAAI Boston Annual Scientific Meeting, The Hynes Convention Center November 12-17, 2004, P71 (pg.42)
  41. N.N. Kim, K.Y. Yoon, K.T. Kim, Sensitivity of exhaled nitrous oxide in detecting airway inflammation. Abstract Book ACAAI Boston Annual Scientific Meeting, The Hynes Convention Center November 12-17,2004, P87 (pg. 46
  42. K.T. Kim, E.M. Kerwin, L. Landwehr, J. Wanger, P. Johnson, C.C. Wood, K. Drda, Safety and efficacy of ipratropium bromide nasal spray 0.06% in children 2 to 5 years of age with rhinorrhea associated with a common cold or allergy. Abstract Book ACAAI Boston Annual Scientific Meeting, The Hynes Convention Center November 12-17, 2004 P181 (pg.72)
  43. K.T. Kim, E.M. Kerwin, L. Landwehr, J. Wanger, P. Johnson, C.C. Wood, K. Drda, Safety and efficacy of Ipratropium Bromide Nasal Spray 0.06% in children 2 to 5 years of age with rhinorrhea associated with a common cold or allergy, Annals of Allergy, Asthma & Immunology,Vol. 94 (1)176:P181 January 2005
  44. Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, Small I, Dutowski R, Ward P, Carr J, Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without post exposure prophylaxis, J Infect Dis. 2004 Feb 1; 189(3):440-9. Epub 2004 Jan 26
  45. E.M. Kerwin, MD, M.M. Tarpay, MD, K. Kim, MD, M.J. Noonan, MD, W. Lincourt, BS, R. Trivedi, MS, A. Ellsworth, BS, A. Davis-Allen, MD, Safety and Efficacy of a New Albuterol Hydrofluoroalkane Formulation for Treating Asthma Symptoms in Children 2 to Less than 4 Years of Age, Pediatric Asthma, Allergy and Immunology Journal
    [view in a new window]
  46. Kenneth Kim, M.D., Javier Quesada, D.O., Nancy Szmaydy-Rikken, B.A., Patrick Darken, Ph.D., and Tushar Shah, M.D. Intranasal Ciclesonide Co administration With Inhaled Fluticasone Propionate-Salmeterol Does Not Suppress Cortisol in Allergic Rhinitis Patients, American Thoracic Society, May 18-23, 2007; San Francisco, CA; American Academy of Allergy, Asthma & Immunology, February 23-27, 2007; San Diego, CA (Submitted to Journal of Asthma)
    [view in a new window]
  47. K.T. Kim, H. Milgrom, Y.K. Yoon, A.L. Levy, P. Matz, M.J. Welch, A. Cahn, D.A. Collins, S. Kathman, R. Mehta, S. Su, R.L. Kunka, Children ages 4 to 11 years have lower systemic exposure to fluticasone propionate (FP) when treated with FP HFA than with FP CFC and FP HFA Does not affect urinary cortisol, Annals of Allergy, Asthma & Immunology. Vol. 98 (1) A58:P87, January 2007; Journal of Clinical Pharmacology 2008 Jan; 48(1):108-16.
    [view in a new window]
  48. K.T. Kim, M. Weiswasser, P. Ratner, A. Nayak, J. Herron, N. Hall, M. Wingertzahn, Safety of Once-Daily Ciclesonide Nasal Spray in Children With Perennial Allergic Rhinitis; Pediatric Asthma, Allergy and Immunology Journal (Submitted); American Academy of Otolaryngic Allergy, September 13-17, 2007; Washington DC (Submitted)
  49. K.T. Kim, M. Weiswasser, P. Ratner, A. Nayak, J. Herron, N. Hall, M. Wingertzahn, Safety of Once-Daily Ciclesonide Nasal Spray in Children 2 To 5 Years Old With Perennial Allergic Rhinitis; American Academy of Pediatrics Meeting October 27-30, 2007, San Francisco, CA, Pediatric Asthma, Allergy & Immunology, December 1, 2007, 20 (4):229-242, also in Annals of Allergy Asthma & Immunology, January 2008, (suppl) pg A3:2
  50. K. T. Kim, B. K. Birmingham, C. T Azumaya, J. Zalikowski, Y. Chen, D. Schneck, Increased Systemic Exposure to Rosuvastatin in Asian Subjects Residing in the United States Compared to Caucasian Subjects, American Society for Clinical Pharmacology and Therapeutics, , Poster PI:18, April 3, 2008, Orlando World Center Marriott, Orlando, FL. Vol. 83 Sup.1, March 2008
  51. Kim, KT, Sussman, GL, Hebert, J, Lumry, WR, Lutsky, B, Gates, D, Effect of Once Daily Desloratadine in Patients with Perennial Allergic Rhintis:, A Double Blind, Placebo Controlled Study. Journal of Allergy and Clinical Immunology Feb 2003, 111, No 2,#25 allergic rhinitis
    [view in a new window]
  52. Kenneth T Kim, MD, Neils G Borgstein, Md, Yijun Yang, Eric Haltom, Louisa Mook, Michelle D Ababa, MD, Sandeep K Reddy, MD and Matthew Leigh Sherman, MD. Ace-O11, a Soluble Activin Receptor Type lla lgG-FC Fusion Protein, Increases Hemoglobin and Hemtocrit Level in Postmenopausal Healthy Women.
    [view in a new window]

  1. Birmingham, BK, Azumaya, CT,Wei, C , Chen, Y, Schneck, D, Mosqueda-Garcia,R. Increased Exposure Levels of Rosuvastatin, Atovastatin and Simvastatin in Chinese and Japanese subjects a Class Effect, American Society for Clinical Pharmacology and Therapeutics, 2-5 April 2008.
    [view in a new window]
  2. K.T. Kim, B.K. Birmingham, C.T Azumaya, J. Zalikowski, Y. Chen, D. Schneck, Increased Systemic Exposure to Rosuvastatin in Asian Subjects Residing in the United States Compared to Caucasian Subjects, American Society for Clinical Pharmacology and Therapeutics., Poster Pl:18, April 3,2008, Orlando World Center Marriott, Orlando, Fl. Vol. 83 Sup, March 2008
    [view in a new window]
  3. Kenneth Kim, M.D., Javier Quesada, D.O., Nancy Szmaydy-Rikken, B.A., Patrick Darken, Ph.D., and Tushar Shah, M.D. Intranasal Ciclesonide Co administration with inhaled Fluticasone Propionate-Salmeterol does not suppress Cortisol in Allergic Rhinitis Patients
    [view in a new window]
  4. Kenneth Kim, M.D., Javier Quesada, D.O., Nancy Szmaydy-Rikken, B.A., Patrick Darken, Ph.D., and Tushar Shah, M.D. Intranasal Ciclesonide Co administration with inhaled Fluticasone Propionate-Salmeterol does not suppress Cortisol in Allergic Rhintis Patients, American Thoracic Society, May 18-23, 2007; San Francisco, CA; American Academy of Allergy, Asthma and immunology, February 23-27, 2007; San Diego, CA(submitted to Journal Asthma)
    [view in a new window]
  5. Kenneth T Kim, MD, Neils G Borgstein, Md, Yijun Yang, Eric Haltom, Louisa Mook, Michelle D Ababa, MD, Sandeep K Reddy, MD and Matthew Leigh Sherman, MD. Ace-O11, a Soluble Activin Receptor Type IIa IgG-Fc Fusion Protein, Increases Hemoglobin and Hemtocrit Level in Postmenopausal Healthy Women.
    [view in a new window]
  6. Kenneth T. Kim, MD, Bobby Q. Lanier, MD, Mitchell Goldman, MD, PhD, Paula Martin, MS, James Zangrilli, MD. Effect of Adjustable-Dose (AD) Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI), Fixed-Dose (FD) Budesonide/Formoterol pMDI, and FD Fluticasone/Salmeterol Dry Powder Inhaler (DPI) on Predose FEF25%-75%.
    [view in a new window]
West Coast Clinical Trials, LLC Logo. All rights reserved. Home | Company | For Sponsors | For Volunteers | Contact us
© 2009 West Coast Clinical Trials, LLC. All Rights Reserved.